Neuropeptide Y (NPY) potentiates phenylephrine-induced mitogen-activated protein kinase activation in primary cardiomyocytes via NPY Y5 receptors

Proceedings of the National Academy of Sciences of the United States of America

Volumn 97, Issue 4, 2000, Pages 1595-1600

  Pellieux, Corinne ^a   Sauthier, Thérèse ^a   Domenighetti, Andrea ^a   Marsh, Donald J ^b   Palmiter, Richard D ^b   Brunner, Hans R ^a   Pedrazzini, Thierry ^a  

^a University of Lausanne Medical Center   (Switzerland)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE KINASE; NEUROPEPTIDE Y; NEUROPEPTIDE Y5 RECEPTOR; PHENYLEPHRINE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SYMPATHETIC TONE;

ANGIOTENSIN II; ANIMALS; CELLS, CULTURED; ENZYME ACTIVATION; MICE; MICE, INBRED C57BL; MITOGEN-ACTIVATED PROTEIN KINASES; MYOCARDIUM; NEUROPEPTIDE Y; PERTUSSIS TOXIN; PHENYLEPHRINE; PHOSPHORYLATION; PROTEIN KINASE C; RECEPTORS, NEUROPEPTIDE Y; RNA, MESSENGER; TETRADECANOYLPHORBOL ACETATE; THAPSIGARGIN; VIRULENCE FACTORS, BORDETELLA;

ANIMALIA;

EID: 0034652355     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.030533197     Document Type: Article

References (37)

1. Tatemoto, K. (1982) Proc. Natl. Acad. Sci. USA 79, 5485-5489.
2. Gray, T. S. & Morley, J. E. (1986) Life Sci. 38, 389-401.
3. Dumont, Y., Martel, J. C., Fournier, A., St.-Pierre, S. & Quirion, R. (1992) Prog. Neurobiol. 38, 125-167.
4. Grundemar, L. & Hakanson, R. (1993) Gen. Pharmacol. 24, 785-796.
5. Stanley, B. G., Kyrkouli, S. E., Lampert, S. F. & Leibowitz, S. F. (1986) Peptides 7, 1189-1192.
6. Walker, P., Grouzmann, E., Burnier, M. & Waeber, B. (1991) Trends Pharmacol. Sci. 12, 111-115.
7. Aubert, J.-F., Waeber, B., Rossier, B., Geering, K., Nussberger, J. & Brunner, H.-R. (1988) J. Pharmacol. Exp. Ther. 246, 1088-1092.
8. Linder, L., Lautenschlager, B. M. & Haefeli, W. (1996) Hypertension 28, 483-487.
9. Michel, M. C. (1991) Trends Pharmacol. Sci. 12, 389-394.
10. Michel, M. C. Beck-Sickinger, A. G., Cox, H., Doods, H. N., Herzog, H., Larhammar, D., Quirion, R., Schwartz, T. & Westfall, T. (1998) Pharmacol. Rev. 50, 143-150.
11. Motulsky, H. J. & Michel. M. C. (1988) Am. J. Physiol. 255, E880-E885.
12. Selbie, L. A., Darby, K., Scmitz-Peiffer, C., Browne, C. L., Herzog, H., Shine, J. & Biden, T. J. (1995) J. Biol. Chem. 270, 11789-11796.
13. Mihara, S., Shigeri, Y. & Fujimoto, M. (1989) FEBS Lett. 259, 79-82.
14. Goldberg, Y., Taimor, G., Piper, H. M. & Schluter, K. D. (1998) Am. J. Physiol. 275, C1207-C1215.
15. Zimmer, H. G. (1997) J. Mol. Med. 75, 849-859.
16. Rockman, H. A., Koch, W. J. & Lefkowitz, R. J. (1997) Am. J. Physiol. 272, H1553-H1559.
17. Page, C. & Doubell, A. F. (1996) Mol. Cell. Biochem. 157, 49-57.
18. Sugden, P. H. & Clerk, A. (1998) J. Mol. Med. 76, 725-746.
19. Bogoyevitch, M. A., Glennon, P. E., Andersson, M. B., Clerk, A., Lazou, A., Marshall, C. J., Parker, P. J. & Sugden, P. H. (1994) J. Biol. Chem. 269, 1110-1119.
20. Clerk, A., Bogoyevitch, M. A., Andersson, M. B. & Sugden, P. H. (1994) J. Biol. Chem. 269, 32848-32857.
21. Tamirisa, P., Blumer, K. J. & Muslin, A. J. (1999) Circulation 99, 441-447.
22. Dostal, D. E., Hunt, R. A., Kule, C. E., Bhat, G. J., Karoor, V., McWhinney, C. D. & Baker, K. M. (1997) J. Mol. Cell. Cardiol. 29, 2893-2902.
23. Clerk, A., Michael, A. & Sugden, P. H. (1998) J. Cell. Biol. 142, 523-535.
24. Zukowska-Grojec, Z., Karwatowska-Prokopczuk, E., Fisher, T. A. & Ji, H. (1998) Regul. Pept. 75-76, 231-238.
25. Nie, M. & Selbie, L. A. (1998) Regul. Pept. 25, 207-213.
26. Millar, B. C., Piper, H. M. & McDermott, B. J. (1994) Am. J. Physiol. 266, C1271-C1277.
27. Pedrazzini, T., Seydoux, J., Kustner, P., Aubert, J., Grouzmann, E., Beermann, F. & Brunner, H. R. (1998) Nat. Med. 4, 722-726.
28. Marsh, D. J., Hollopeter, G., Kafer, K. E. & Palmiter, R. D. (1998) Nat. Med. 4, 718-721.
29. Leenen, F. H. H. (1999) Can. J. Cardiol. 15, 2A-7A.
30. Glennon, P. E., Kaddoura, S., Sale, E. M., Sale, G. J., Fuller, S. J. & Sugden, P. H. (1996) Circ. Res. 78, 954-961.
31. Haggblad, J. & Fredholm, B. B. (1987) J. Neurosci. Lett. 82, 211-216.
32. Duckles, S. P. & Buxton, I. L. O. (1994) Life Sci. 55, 103-109.
33. Sadoshima, J., Qiu, Z., Morgan, J. P. & Izumo, S. (1995) Circ. Res. 76, 1-15.
34. Selbie, L. A. & Hill, S. J. (1998) Trends Pharmacol. Sci. 19, 87-93.
35. Sun, L. S., Rybin, V. O., Steinberg, S. F. & Robinson, R. B. (1998) Eur. J. Pharmacol. 349, 377-381.
36. Goo Rhee, S. & Soo Bae, Y. (1997) J. Biol. Chem. 272, 15045-15048.
37. Sadoshima, J.-I. & Izumo, S. (1996) EMBO J. 15, 775-787.